Furthermore, CD4+ T-cells in the pleural fluid of patients with either metastatic carcinomas or benign pleural lesions associated with asbestos exposure tended to be relatively more abundant than in MPM patients (Figure 2A). Here, CD4 is linked to metastatic carcinoma.